Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence? - Test2 - elhamkhani - TriplyDB

Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

http://www.wikidata.org/entity/Q38678295

about

Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.Myeloid Populations in Systemic Autoimmune Diseases.Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk.Effects of scavenger receptors-1 class A stimulation on macrophage morphology and highly modified advanced glycation end product-protein phagocytosis.RGC32 Promotes Bleomycin-Induced Systemic Sclerosis in a Murine Disease Model by Modulating Classically Activated Macrophage Function.Soluble CD163 as a Potential Biomarker in Systemic Sclerosis.Distinct Properties of Human M-CSF and GM-CSF Monocyte-Derived Macrophages to Simulate Pathological Lung Conditions In Vitro: Application to Systemic and Inflammatory Disorders with Pulmonary Involvement.Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement

P2860

Q26749091-7287245B-8330-4105-A2C4-5ED545BFB89A Q36192785-C326D52D-F3CC-4181-AB42-AED92F6A7C2A Q38772739-D4C02F42-2BA6-47F3-870E-A9C15DD46EC0 Q49953534-E1B1FBA8-F91E-40A6-A185-EA18FF2054CC Q52590915-5C773B11-9E05-4883-9950-A3E70FE13512 Q52673265-D49FD5BE-0400-4CCD-9F15-0D66D42E9587 Q55286227-728B2110-2662-4CBD-863A-D99511FE59D4 Q55301900-B3E51FAB-6A11-4C53-8FD6-C834773774FA Q57175037-5398CDC4-FF0B-4246-B71D-81B2B0159471 Q58700783-C4CF6896-29E5-4DCC-A97D-3A7572EA43EA

P2860

Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

http://www.wikidata.org/entity/Q38678295

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

@en

type

label

Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

@en

prefLabel

Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

@en

P1433

Q38678295-94213DAC-1B5C-4092-B651-9E4783B8D9F2

P1476

Q38678295-60AA166A-0497-4396-912C-4B1149AECE87

P2093

Q38678295-B6BB2E56-4DBC-4766-B1D5-1A73A01D9DD6

Q38678295-B8BC36F5-B9CA-4509-9F13-6F1841F99928

P2860

Q38678295-04407BED-C42B-4DC4-9D53-D194661336AC

Q38678295-058A8B95-62D2-48A5-9D53-557FB74D52C1

Q38678295-0692389E-31B8-428B-9CEB-69EE315641CE

Q38678295-0B58D0C8-FEE0-44AA-A0C5-6DC852AA73FC

Q38678295-0E93A977-D265-4DFF-98A0-DFDDFD4885E1

Q38678295-282B6299-4727-4381-B65A-5D76884D120D

Q38678295-38682B88-2E56-479E-8413-79B46E91A002

Q38678295-4563A2AA-B8B7-449A-B5D7-30DD84365EE8

Q38678295-51CE12EE-69DF-4AF7-AE8F-B218E6B59ED3

Q38678295-5619D42A-2989-48D3-A7C6-C38F840566FD

P2888

Q38678295-3B99B212-38E1-405C-839D-5E504F10D3DE

P304

Q38678295-FB0C2281-35A1-4B20-8658-6AF09B8AC72C

P31

Q38678295-CE144EE6-7DD5-4B1A-A5D3-2C4449A6F49B

P356

Q38678295-3EF014D9-9945-429D-9E15-08E28F42BC35

P433

Q38678295-729DBF1D-7CAB-48DA-B85B-49E64F605427

P478

Q38678295-C8435AD7-952E-4B75-9E5A-0058FC693C36

P577

Q38678295-25CCD56F-BBE5-41B8-A628-1832BB255710

P6179

Q38678295-BD9EF85D-6E93-40F3-B0FC-E88B5F34E282

P698

Q38678295-769B1039-AA36-443C-8048-05BF0C06B559

P921

Q38678295-A693E3D4-22DE-489E-9685-31EA7B7C6A75

P356

S11926-015-0554-8

P1433

Current Rheumatology Reports

P1476

Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

@en

P2093

Giuseppina Stifano

http://www.w3.org/2001/XMLSchema#string

Romy Beatriz Christmann

http://www.w3.org/2001/XMLSchema#string

P2860

Exploring the full spectrum of macrophage activation

A Hitchhiker's Guide to Myeloid Cell Subsets: Practical Implementation of a Novel Mononuclear Phagocyte Classification System

Alternative activation of macrophages

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

The chemokine system in diverse forms of macrophage activation and polarization

The M1 and M2 paradigm of macrophage activation: time for reassessment

Protective and pathogenic functions of macrophage subsets

Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.

Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.

High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.

P2888

s11926-015-0554-8

P304

2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-015-0554-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1049975197

http://www.w3.org/2001/XMLSchema#string

P698

26700912

http://www.w3.org/2001/XMLSchema#string

P921